Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT: Probiotics in ICU Patients
NCT01782755Phase 2Completed
- Sponsor
- McMaster University
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in ventilator-associated pneumonia (VAP), Infection, sponsored by McMaster University. Started Oct 2013; status: completed.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
ventilator-associated pneumonia (VAP)Infection
Beyond the preview
Go deeper on NCT01782755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782755.